DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/hllhkn/u_s_market_for) has announced the addition of the "U.S. Market for ENT and Bronchoscopic Devices 2012 (Executive Summary)" report to their offering.
In 2011, the U.S. market for ENT and bronchoscopic devices was valued at nearly $427 million.
The U.S. market for ENT and Bronchoscopic Devices Includes:
- ENT powered instruments,
- Radiofrequency (RF) and ultrasonic devices,
- ENT hand instruments,
- Bronchial biopsy forceps and
- Transbronchial aspiration (TBNA) needles, foreign body removal devices and bronchial hand instruments
The ENT device market was driven by the ENT powered instrument and RF and ultrasonic device segments, while the bronchoscopic device market was driven by the bronchoscope, biopsy forcep and TBNA needle segments.
Within the U.S. ENT and Bronchoscopic Device market, companies such as Arthrocare, Boston Scientific, Karl Storz, Medtronic, Xomed and Olympus lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
For more information visit http://www.researchandmarkets.com/research/hllhkn/u_s_market_for